📰 Transcode Therapeutics News
Page 4 - Transcode Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Transcode Therapeutics. Real-time updates on events, politics, business and more.
September 26, 2023
By Colin Kellaher Shares of TransCode Therapeutics plunged in premarket trading Tuesday following a steep run-up in its stock price on Monday, after the RNA...
September 26, 2023
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...
September 25, 2023
By Ben Glickman Shares of TransCode Therapeutics jumped Monday after reporting positive study results for its lead cancer treatment candidate. The stock was...
September 25, 2023
TransCode Therapeutics, Inc. (RNAZ) shares are surging more than 163 percent on Monday morning trade after the company announced positive results with its TTX-MC138, in murine models bearing human glioblastoma multiforme or GBM tumors.
September 25, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With TransCode Therapeutics delivering positive pre-clinical results for its brain tumor…
September 14, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the recipient of a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 24,400 shares, an increase of 1,255.6% from the August 15th total of 1,800 shares. Based on an average daily trading volume, of 154,400 […]